Donald Hedeker to Clinical Trials as Topic
This is a "connection" page, showing publications Donald Hedeker has written about Clinical Trials as Topic.
Connection Strength
0.498
-
An Introduction and Practical Guide to Strategies for Analyzing Longitudinal Data in Clinical Trials of Smoking Cessation Treatment: Beyond Dichotomous Point-Prevalence Outcomes. Nicotine Tob Res. 2024 Jun 21; 26(7):796-805.
Score: 0.148
-
Joint modeling the frequency and duration of accelerometer-measured physical activity from a lifestyle intervention trial. Stat Med. 2023 12 10; 42(28):5100-5112.
Score: 0.141
-
A random-effects mixture model for classifying treatment response in longitudinal clinical trials. J Biopharm Stat. 2001 Nov; 11(4):253-73.
Score: 0.124
-
Analysis of binary outcomes with missing data: missing = smoking, last observation carried forward, and a little multiple imputation. Addiction. 2007 Oct; 102(10):1564-73.
Score: 0.047
-
Random effects probit and logistic regression models for three-level data. Biometrics. 1997 Dec; 53(4):1527-37.
Score: 0.024
-
Bias reduction in effectiveness analyses of longitudinal ordinal doses with a mixed-effects propensity adjustment. Stat Med. 2007 Jan 15; 26(1):110-23.
Score: 0.011
-
Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset. Arch Gen Psychiatry. 1993 Sep; 50(9):739-50.
Score: 0.004